Moreover, the presence of terminal complement components including C5b-9 (membrane attack complex/MAC), C4d, and mannose-binding lectin (MBL)-associated serine protease (MASP2) within the pulmonary microvasculature and purpuric skin lesions of deceased COVID-19 patients [36]. The gene discussed is MBL2; the disease is COVID-19.